Deakin University
Browse

File(s) under permanent embargo

An in vivo cytotoxicity threshold for influenza A virus-specific effector and memory CD8+ T cells

journal contribution
posted on 2007-02-01, 00:00 authored by John StambasJohn Stambas, P Doherty, S Turner
Influenza A virus infection of C57BL/6 (B6) mice is characterized by prominent CD8 T cell responses to H2Db complexed with peptides from the viral nucleoprotein (NP366, ASNENMETM) and acid polymerase (PA224, SSLENFRAYV). An in vivo cytotoxicity assay that depends on the adoptive transfer of peptide-pulsed, syngeneic targets was used in this study to quantitate the cytotoxic potential of DbNP366- and DbPA224-specific acute and memory CD8 T cells following primary or secondary virus challenge. Both T cell populations displayed equivalent levels of in vivo effector function when comparable numbers were transferred into naive B6 hosts. Cytotoxic activity following primary infection clearly correlated with the frequency of tetramer-stained CD8 T cells. This relationship looked, however, to be less direct following secondary exposure, partly because the numbers of CD8DbNP366 T cells were greatly in excess. However, calculating the in vivo E:T ratios indicated that in vivo lysis, like many other biological functions, is threshold dependent. Furthermore, the capacity to eliminate peptide-pulsed targets was independent of the differentiation state (i.e., primary or secondary effectors) and was comparable for the two T cell specificities that were analyzed. These experiments provide insights that may be of value for adoptive immunotherapy, where careful consideration of both the activation state and the number of effector cells is required.

History

Journal

The Journal of Immunology

Volume

178

Issue

3

Pagination

1285 - 1292

Publisher

American Association of Immunologists

Location

Baltimore, Md.

ISSN

0022-1767

eISSN

1550-6606

Language

eng

Publication classification

C1.1 Refereed article in a scholarly journal

Copyright notice

Copyright 2007 by The American Association of Immunologists, Inc. All rights reserved.